Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Nerve Grafting After Bilateral Nipple-Sparing Mastectomy
NCT07819357Phase 4Not yet recruiting
- Sponsor
- Endeavor Health
- Start
- Dec 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breast reconstruction (2 arms), sponsored by Endeavor Health. Primary endpoint: Breast Sensation Measured by Semmes-Weinstein Monofilament Testing at 24 months. Planned start Dec 2026; status: not yet recruiting.
02
Conditions
breast reconstruction
Beyond the preview
Go deeper on NCT07819357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819357.